Concepedia

Stephen B. Hanauer

SB

Statistics

Publications

171

Citations

29.9K

H-Index

69

Active since

1986

Affiliations

Northwestern University(Current)

University of Chicago

University of Chicago Medical Center

University of California San Diego

Icahn School of Medicine at Mount Sinai

Stephen B. Hanauer is an author at Northwestern University specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and medicine.

ORCID

Publications per year

1986–2024

171

Publications

171

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

, , +12

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

, , +17

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Stephen B. Hanauer, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 1.7K citations

, , +13

Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab

William J. Sandborn, Paul Rutgeerts, Robert Enns et al. · Annals of Internal Medicine · 2007 · 960 citations

, , +17

1–5 of 171